Phase II study of bevacizumab and erlotinib in patients with recurrent glioblastoma multiforme

被引：0
|
作者：
Sathornsumetee, S. [1 ]
Vredenburgh, J. J. [1 ]
Rich, J. N. [1 ]
Desjardins, A. [1 ]
Quinn, J. A. [1 ]
Mathe, A. E. [1 ]
Gururangan, S. [1 ]
Friedman, A. H. [1 ]
Friedman, H. S. [1 ]
Reardon, D. A. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13008
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
    Reardon, David A.
    Sathornsumetee, Sith
    Vredenburgh, James J.
    Rich, Jeremy N.
    Desjardins, Annick
    Quinn, Jennifer A.
    Mathe, Alyssa
    Gururangan, Sridharan
    Friedman, Allen H.
    Friedman, Henry S.
    [J]. NEURO-ONCOLOGY, 2009, 11 (02) : 231 - 231
  • [2] Phase II trial of bevacizumab and erlotinib in recurrent glioblastoma multiforme (GBM)
    Sathornsumetee, Sith
    Vredenburgh, James
    Rich, Jeremy
    Desjardins, Annick
    Quinn, Jennifer
    Bota, Daniela
    Goli, Krishna
    Mathe, Alyssa
    Gururangan, Sridharan
    Friedman, Allan
    Friedman, Henry
    Reardon, David
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 516 - 516
  • [3] Phase II study of combination carboplatin and erlotinib in patients with recurrent glioblastoma multiforme
    De Groot, J. F.
    Gilbert, M. R.
    Hess, K. R.
    Hanna, T.
    Groves, M.
    Conrad, C.
    Aldape, K.
    Colman, H.
    Puduvalli, V.
    Yung, W. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] SAFETY AND EFFICACY OF BEVACIZUMAB AND ERLOTINIB FOR RECURRENT GLIOBLASTOMA PATIENTS IN A PHASE II STUDY
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James
    Rich, Jeremy
    Gururangan, Sridharan
    Friedman, Allan
    Friedman, Henry
    Reardon, David
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 827 - 827
  • [5] Phase II study of erlotinib single agent therapy in recurrent glioblastoma multiforme
    Vogelbaum, M.
    Peereboom, D.
    Stevens, G.
    Barnett, G.
    Brewer, C.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 135 - 135
  • [6] A randomized phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET)
    Field, Kathryn Maree
    Simes, John
    Wheeler, Helen
    Hovey, Elizabeth J.
    Nowak, Anna K.
    Cher, Lawrence
    Brown, Chris
    Livingstone, Ann
    Sawkins, Kate
    Rosenthal, Mark
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Phase II Study of Bevacizumab and Temsirolimus Combination Therapy for Recurrent Glioblastoma Multiforme
    Lassen, Ulrik
    Sorensen, Morten
    Gaziel, Tine Bernhardtsen
    Hasselbalch, Benedikte
    Poulsen, Hans Skovgaard
    [J]. ANTICANCER RESEARCH, 2013, 33 (04) : 1657 - 1660
  • [8] NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme
    Peereboom, David M.
    Ahluwalia, Manmeet S.
    Ye, Xiaobu
    Supko, Jeffrey G.
    Hilderbrand, Sarah L.
    Phuphanich, Surasak
    Nabors, L. Burt
    Rosenfeld, Myrna R.
    Mikkelsen, Tom
    Grossman, Stuart A.
    [J]. NEURO-ONCOLOGY, 2013, 15 (04) : 490 - 496
  • [9] A RANDOMIZED PHASE II STUDY OF CARBOPLATIN AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME ( CABARET STUDY)
    Field, Kathryn M.
    Cher, Lawrence
    Wheeler, Helen
    Hovey, Elizabeth
    Nowak, Anna K.
    Simes, John
    Sawkins, Kate
    France, Trevor
    Brown, Chris
    [J]. NEURO-ONCOLOGY, 2011, 13 : 88 - 88
  • [10] A RANDOMISED PHASE II STUDY OF CARBOPLATIN AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME (CABARET STUDY)
    Field, Kathryn M.
    Simes, John
    Nowak, Anna K.
    Hovey, Elizabeth
    Wheeler, Helen
    Cher, Lawrence
    Brown, Chris
    Livingstone, Ann
    Sawkins, Kate
    Rosenthal, Mark A.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 101 - 102
12345